Apogee to Present phase 1 Clinical Trial Results at the 2013 Molecular Targets and Cancer Therapeutics Meeting

Published: Oct 01, 2013

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Apogee will present interim data from the first-in-human trial of ABC294640 entitled “A Phase I, Open-Label, Dose-Escalation Safety, Pharmacokinetic and Pharmacodynamic Study of ABC294640 in Patients with Advanced Solid Tumors” at the Molecular Targets and Cancer Therapeutics meeting in Boston on Tuesday, October 22.

Help employers find you! Check out all the jobs and post your resume.

Back to news